Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2000
10/17/2000US6133326 Compositions and methods for decreasing sebum production
10/17/2000US6133309 Treatment of T-helper cell type 2-mediated immune disease by retinoid antagonists
10/17/2000US6133295 Pharmaceutical composition
10/17/2000US6133293 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action; potent depressive effect on diabetic hyperglycemia; 2,4-thiazolidinediones and oxazolidinediones
10/17/2000US6133250 Oral 1α-hydroxyprevitamin D in methods for increasing blood level of activated vitamin D
10/17/2000US6133249 Phospholipid and propylene glycol based lubricant
10/17/2000US6133248 Polar drug of prodrug compositions with extended shelf-life storage and a method of making thereof
10/17/2000US6133247 Method of detecting lung disease
10/17/2000US6133032 Antisense modulation of PI3 kinase p110 beta expression
10/17/2000US6133026 Condensed plasmid-liposome complex for transfection
10/17/2000US6133024 Recombinant vector which codes for an rna capable of forming a triple helix with target nucleic acid; for transcription of the rna in target cells
10/17/2000US6132789 For vaccine formulations as adjuvants and/or delivery systems, to enhance immune response to immunogens in animal such as human
10/17/2000US6132772 Extended-release solid oral dosage forms of drugs having low solubility in water
10/17/2000US6132771 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
10/17/2000US6132770 Multiple unit effervescent dosage forms comprising proton pump inhibitor
10/17/2000US6132769 Controlled release
10/17/2000US6132768 Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
10/17/2000US6132766 For drug delivery system; controlls release rate of encapsulated biologically active substance into biological fluids and in vivo
10/17/2000US6132765 Vehicle for effecting drug delivery from solid substrate; useful in treatment and prevention of biofilm mediated infection often associated with the use of in-dwelling medical devices, e.g. implants, catheters
10/17/2000US6132763 Liposomes
10/17/2000US6132762 Transcutaneous application of marijuana
10/17/2000US6132761 Percutaneous absorption preparation
10/17/2000US6132760 Contains a therapeutically effective amount of testosterone and a delivery enhancing adjuvant comprising a terpene.
10/17/2000US6132759 Medicaments containing gelatin cross-linked with oxidized polysaccharides
10/17/2000US6132758 A loratadine and an aminopolycarboxylic acid or a salt thereof.
10/17/2000US6132755 Transcorneal drug-release system
10/17/2000US6132752 Electro-release systems, modified electrodes and their use
10/17/2000US6132751 Comprises a drug selected from the group consisting of fluorometholone, clobetasone butyrate and clobetasol propionate; a phospholipid; liquid paraffine; and water.
10/17/2000US6132750 Particles of cross-linked proteins and polysaccharides with hydroxamic groups for chelating metals and their uses notably in cosmetics
10/17/2000US6132738 Shower preparations having a high oil content
10/17/2000US6132659 Rolling and counter rolling, molding and melting
10/17/2000US6132463 Cell seeding of ceramic compositions
10/17/2000US6132420 Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
10/17/2000US6131567 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
10/17/2000US6131566 Metered dose inhaler for albuterol
10/17/2000CA2204621C Cleaning tissues treated with water-in-lipid emulsion
10/17/2000CA2193497C Controlled release aqueous emulsion
10/17/2000CA2182157C Composition for a dietary supplement for the treatment of hemorrhoids
10/17/2000CA2156726C Bisacodyl dosage form
10/17/2000CA2148071C Method of administering azithromycin
10/17/2000CA2134855C Gelatin powders with improved tabletability, color and odor characteristics
10/17/2000CA2009221C Spray preparations for respiratory tract infections
10/15/2000CA2269381A1 Bioresorbable polymeric clayey and sticky substance
10/12/2000WO2000060051A2 Arpe-19 as a platform cell line for encapsulated cell-based delivery
10/12/2000WO2000059963A1 Fluorinated copolymers for coating biomedical devices and a process for their manufacture
10/12/2000WO2000059947A1 Enhanced gel strength methylcellulose
10/12/2000WO2000059863A1 Disodium salts, monohydrates, and ethanol solvates
10/12/2000WO2000059851A1 Derivatives of venlafaxine and methods of preparing and using the same
10/12/2000WO2000059629A1 Process for producing anion-layered double hydroxide intercalation compounds and products thus produced
10/12/2000WO2000059577A1 Low dose estrogen interrupted hormone replacement therapy
10/12/2000WO2000059548A1 Polyethyleneimine:dna formulations for aerosol delivery
10/12/2000WO2000059544A1 Stabilized compositions containing nootropic drugs
10/12/2000WO2000059543A1 Over-coated chewing gum formulations
10/12/2000WO2000059527A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
10/12/2000WO2000059518A2 Composition and method for inducing apoptosis in prostate cancer cells
10/12/2000WO2000059516A1 Compositions of polyacids and polyethers and methods for their use in reducing adhesions
10/12/2000WO2000059512A1 Formulation comprising testosteron undecanoate and castor oil
10/12/2000WO2000059508A1 Tolperison-containing, pharmaceutical preparation for oral administration
10/12/2000WO2000059500A1 Swallowable tablets with high content of n-acetylcysteine
10/12/2000WO2000059491A2 Methods for modulating the human sexual response
10/12/2000WO2000059489A2 Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites
10/12/2000WO2000059483A2 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000WO2000059482A1 Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants
10/12/2000WO2000059481A1 PHARMACEUTICAL DOSAGE FORM FOR PULSATILE DELIVERY OF d-threo-METHYLPHENIDATE AND A SECOND CNS STIMULANT
10/12/2000WO2000059480A1 Lyophilized solid dosage forms and methods of making
10/12/2000WO2000059479A1 Pharmaceutical dosage form for pulsatile delivery of methylphenidate
10/12/2000WO2000059478A1 Stabilised polyvinylpyrrolidone formulation
10/12/2000WO2000059477A1 Pregelatinized starch in a controlled release formulation
10/12/2000WO2000059476A1 Methods for fine powder formation
10/12/2000WO2000059475A1 Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
10/12/2000WO2000059474A1 Fusogenic lipids and vesicles
10/12/2000WO2000059473A1 Compositions and methods for treating lymphoma
10/12/2000WO2000059472A1 Propofol compositions containing preservative additives
10/12/2000WO2000059471A1 Propofol formulation with enhanced microbial characteristics
10/12/2000WO2000059470A1 Emulsion and process for producing the same
10/12/2000WO2000059469A2 Endodontic fibers and methods of use therefor
10/12/2000WO2000059468A1 Drinkable pharmaceutical solution
10/12/2000WO2000059467A1 Drinkable ibuprofen pharmaceutical suspension
10/12/2000WO2000059462A1 Composition for cosmetic and dermatological skin care
10/12/2000WO2000059447A2 Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding
10/12/2000WO2000059424A1 Vacuum assisted closure system with provision for introduction of agent
10/12/2000WO2000059423A1 Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
10/12/2000WO2000059420A1 Improved conjunctival inserts for topical delivery of medication or lubrication
10/12/2000WO2000038747A3 Absorbent article composition and method of use for sequestering skin irritants
10/12/2000WO2000035422A3 Method of administering a compound to multi-drug resistant cells
10/12/2000WO2000033869A3 Use of human prostrate cell lines in cancer treatment
10/12/2000WO2000033820A3 Nanoparticulate core-shell systems and use thereof in pharmaceutical and cosmetic preparations
10/12/2000WO2000033811A3 Improvements in or relating to powders
10/12/2000WO1999065538A9 Medical device having anti-infective and contraceptive properties
10/12/2000WO1999063972A9 Pharmaceutical product and methods and apparatus for making same
10/12/2000DE19915420A1 Stabilisierte Polyvinylpyrrolidon-Zubereitungen Stabilized polyvinyl preparations
10/12/2000CA2369024A1 Negative pressure wound therapy system with provision for introduction of agent
10/12/2000CA2368387A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
10/12/2000CA2368367A1 Pharmaceutical dosage form for pulsatile delivery of methylphenidate
10/12/2000CA2368185A1 Polyethyleneimine:dna formulations for aerosol delivery
10/12/2000CA2368083A1 Derivatives of venlafaxine and methods of preparing and using the same
10/12/2000CA2368071A1 Improved conjunctival inserts for topical delivery of medication or lubrication
10/12/2000CA2367100A1 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000CA2366903A1 Methods for modulating the human sexual response
10/12/2000CA2366880A1 Compositions of polyacids and polyethers and methods for their use in reducing adhesions
1 ... 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 ... 2991